Modofi Bio, a New Haven, CT-based company which specializes in DNA modification as a novel approach to target cancer, raised additional $4.3M in Seed funding. The round included existing investors Connecticut Innovation, HighCape Capital, Advantage Capital (Ironwood) and the National Brain Tumor Society, while also adding new investors Pathway BioVentures, The Sontag Foundation, and BrightEdge, [...]The post Modifi Bio Raises Additional $4.3M in Seed Funding appeared first on FinSMEs.